{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T23:48:49Z","timestamp":1789084129948,"version":"build-2803163510"},"reference-count":100,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100014413","name":"Wy\u017csza Szko\u0142a Informatyki i Zarzadzania z siedziba w Rzeszowie","doi-asserted-by":"publisher","award":["503-07-01-77"],"award-info":[{"award-number":["503-07-01-77"]}],"id":[{"id":"10.13039\/501100014413","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.neuropharm.2025.110781","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T16:55:12Z","timestamp":1764003312000},"page":"110781","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Multi-kinase-mediated alterations in Tau phosphorylation, synaptic proteins, and choline metabolism in a human neuronal in vitro model exposed to the elastin-derived hexapeptide VGVAPG"],"prefix":"10.1016","volume":"284","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7833-9985","authenticated-orcid":false,"given":"Bartosz","family":"Sk\u00f3ra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Piechowiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2207-1160","authenticated-orcid":false,"given":"Konrad A.","family":"Szychowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2025.110781_bib1","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1593\/neo.10328","article-title":"SRC: a century of science brought to the clinic","volume":"12","author":"Aleshin","year":"2010","journal-title":"Neoplasia"},{"key":"10.1016\/j.neuropharm.2025.110781_bib2","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3233\/JAD-231034","article-title":"A meta-analysis on presynaptic changes in alzheimer's disease","volume":"97","author":"Anschuetz","year":"2024","journal-title":"J. Alzheim. Dis."},{"key":"10.1016\/j.neuropharm.2025.110781_bib3","series-title":"Elastin\u2010Elastases and Inflamm\u2010Aging","first-page":"99","author":"Antonicelli","year":"2007"},{"key":"10.1016\/j.neuropharm.2025.110781_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.130090","article-title":"Harnessing memantine in Alzheimer's disease therapy through inhibition of microtubule affinity-regulating kinase: mechanistic insights","volume":"262","author":"Anwar","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.neuropharm.2025.110781_bib5","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0306-4522(86)90243-5","article-title":"Alzheimer plaques and cortical cholinergic innervation","volume":"17","author":"Arendt","year":"1986","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2025.110781_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.653334","article-title":"Role of Neuron and Glia in alzheimer's disease and associated vascular dysfunction","volume":"13","author":"Bandyopadhyay","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110781_bib7","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.2363","article-title":"Active Cdk5 immunoprecipitation and kinase assay","volume":"7","author":"Bankston","year":"2017","journal-title":"BIO-PROTOCOL"},{"key":"10.1016\/j.neuropharm.2025.110781_bib92","doi-asserted-by":"crossref","unstructured":"Barbier P, Zejneli O, Martinho M, et al (2019) Role of Tau as a Microtubule-Associated Protein: Structural and Functional Aspects. Front Aging Neurosci 11:. https:\/\/doi.org\/10.3389\/fnagi.2019.00204.","DOI":"10.3389\/fnagi.2019.00204"},{"key":"10.1016\/j.neuropharm.2025.110781_bib8","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.3390\/ijms22031273","article-title":"The cholinergic system, the adrenergic system and the neuropathology of alzheimer's disease","volume":"22","author":"Bekdash","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2025.110781_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1515\/revneuro-2020-0152","article-title":"SH-SY5Y-derived neurons: a human neuronal model system for investigating TAU sorting and neuronal subtype-specific TAU vulnerability","volume":"33","author":"Bell","year":"2022","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110781_bib10","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1074\/jbc.M112.419929","article-title":"Interaction between the Elastin peptide VGVAPG and human elastin binding protein","volume":"288","author":"Blanchevoye","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2025.110781_bib11","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1750-3639.2008.00195.x","article-title":"Brain extracellular matrix in neurodegeneration","volume":"19","author":"Bonneh\u2010Barkay","year":"2009","journal-title":"Brain Pathol."},{"key":"10.1016\/j.neuropharm.2025.110781_bib12","first-page":"177","article-title":"Amiodarone induced oxidative stress in stress - vulnerable organs of adult male rats","volume":"7","author":"Chakraborty","year":"2014","journal-title":"Asian J. Pharmaceut. Clin. Res."},{"key":"10.1016\/j.neuropharm.2025.110781_bib13","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2414176121","article-title":"GSK3\u03b2 phosphorylation catalyzes the aggregation of Tau into Alzheimer\u2019s disease-like filaments","volume":"121","author":"Chakraborty","year":"2024","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2025.110781_bib14","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12974-023-02853-3","article-title":"Tau and neuroinflammation in Alzheimer's disease: interplay mechanisms and clinical translation","volume":"20","author":"Chen","year":"2023","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuropharm.2025.110781_bib15","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1402627111","article-title":"CDK5 activator protein p25 preferentially binds and activates GSK3\u03b2","volume":"111","author":"Chow","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2025.110781_bib16","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1111\/jnc.15189","article-title":"Tau phosphorylation by glycogen synthase kinase 3\u03b2 modulates enzyme acetylcholinesterase expression","volume":"157","author":"Cort\u00e9s\u2010G\u00f3mez","year":"2021","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2025.110781_bib17","doi-asserted-by":"crossref","first-page":"7355","DOI":"10.1007\/s12035-019-1605-3","article-title":"Cholinergic differentiation of human neuroblastoma SH-SY5Y cell line and its potential use as an In vitro model for alzheimer's disease studies","volume":"56","author":"de Medeiros","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2025.110781_bib18","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1161\/01.ATV.0000168412.50855.9f","article-title":"Elastin-Derived peptides induce a T-Helper type 1 polarization of human blood lymphocytes","volume":"25","author":"Debret","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.neuropharm.2025.110781_bib19","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1096\/fj.08-120410","article-title":"\u03b1\u2010Synuclein contributes to GSK\u20103\u03b2\u2010catalyzed Tau phosphorylation in Parkinson's disease models","volume":"23","author":"Duka","year":"2009","journal-title":"FASEB J."},{"key":"10.1016\/j.neuropharm.2025.110781_bib20","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/bip.20029","article-title":"Structural characterization of VGVAPG, an elastin-derived peptide","volume":"76","author":"Floquet","year":"2004","journal-title":"Biopolym - Pept Sci Sect"},{"key":"10.1016\/j.neuropharm.2025.110781_bib21","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/bip.20029","article-title":"Structural characterization of VGVAPG, an elastin\u2010derived peptide","volume":"76","author":"Floquet","year":"2004","journal-title":"Pept Sci"},{"key":"10.1016\/j.neuropharm.2025.110781_bib22","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/86019","article-title":"Cdk5 is involved in neuregulin-induced AChR expression at the neuromuscular junction","volume":"4","author":"Fu","year":"2001","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110781_bib23","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.patbio.2011.10.006","article-title":"The role of elastin peptides in modulating the immune response in aging and age-related diseases","volume":"60","author":"Fulop","year":"2012","journal-title":"Pathol. Biol."},{"key":"10.1016\/j.neuropharm.2025.110781_bib24","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1242\/jcs.056846","article-title":"MAPK\/Erk-dependent phosphorylation of synapsin mediates formation of functional synapses and short-term homosynaptic plasticity","volume":"123","author":"Giachello","year":"2010","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.neuropharm.2025.110781_bib95","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.2174\/092986708785909111","article-title":"Hyperphosphorylation of Microtubule-Associated Protein Tau: A Promising Therapeutic Target for Alzheimer Disease","volume":"15","author":"Gong","year":"2008","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.neuropharm.2025.110781_bib25","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1002\/(SICI)1522-2683(19990101)20:4\/5<928::AID-ELPS928>3.0.CO;2-Z","article-title":"Decreased levels of synaptosomal associated protein 25 in the brain of patients with Down Syndrome and Alzheimer's disease","volume":"20","author":"Greber","year":"1999","journal-title":"Electrophoresis"},{"key":"10.1016\/j.neuropharm.2025.110781_bib26","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/syn.20939","article-title":"Lack of association between synapsin II (SYN2) gene polymorphism and susceptibility epilepsy: a case\u2013control study and meta\u2010analysis","volume":"65","author":"Haerian","year":"2011","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2025.110781_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2023.137330","article-title":"Biochemical analyses of tau and other neuronal markers in the submandibular gland and frontal cortex across stages of Alzheimer disease","volume":"810","author":"Hamsafar","year":"2023","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2025.110781_bib28","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/35074516","article-title":"ERK induces p35, a neuron-specific activator of Cdk5, through induction of Egr1","volume":"3","author":"Harada","year":"2001","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.neuropharm.2025.110781_bib29","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.3390\/biomedicines12051097","article-title":"Molecular role of protein phosphatases in alzheimer's and other neurodegenerative diseases","volume":"12","author":"Hassan","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.neuropharm.2025.110781_bib30","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1007\/s13311-022-01204-z","article-title":"Chk1 inhibition ameliorates alzheimer's disease pathogenesis and cognitive dysfunction through CIP2A\/PP2A signaling","volume":"19","author":"Hu","year":"2022","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neuropharm.2025.110781_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnrt.2022.100002","article-title":"Acetylcholine bidirectionally regulates learning and memory","volume":"10","author":"Huang","year":"2022","journal-title":"J. Neurorestoratol."},{"key":"10.1016\/j.neuropharm.2025.110781_bib93","doi-asserted-by":"crossref","unstructured":"Iwata M, Watanabe S, Yamane A, et al (2019) Regulatory mechanisms for the axonal localization of tau protein in neurons. Mol Biol Cell 30:2441\u20132457. https:\/\/doi.org\/10.1091\/mbc.E19-03-0183.","DOI":"10.1091\/mbc.E19-03-0183"},{"key":"10.1016\/j.neuropharm.2025.110781_bib32","first-page":"1","article-title":"In vitro oxygen-glucose deprivation-induced stroke models with human neuroblastoma Cell- and induced pluripotent stem cell-derived neurons","author":"Juntunen","year":"2020","journal-title":"Stem Cell. Int."},{"key":"10.1016\/j.neuropharm.2025.110781_bib94","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2021.607303","article-title":"Neuronal and Glial Distribution of Tau Protein in the Adult Rat and Monkey","volume":"14","author":"Kanaan","year":"2021","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.neuropharm.2025.110781_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70401","article-title":"Differences in the soluble and insoluble proteome between primary tauopathies","volume":"21","author":"Kavanagh","year":"2025","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.neuropharm.2025.110781_bib34","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1471-4159.2009.06318.x","article-title":"Calcineurin dephosphorylates glycogen synthase kinase-3 beta at serine-9 in neuroblast-derived cells","volume":"111","author":"Kim","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2025.110781_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2018.00456","article-title":"Nano-architectural approaches for improved intracortical interface technologies","volume":"12","author":"Kim","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110781_bib36","doi-asserted-by":"crossref","first-page":"6758","DOI":"10.1523\/JNEUROSCI.21-17-06758.2001","article-title":"p35 and p39 are essential for cyclin-dependent kinase 5 function during neurodevelopment","volume":"21","author":"Ko","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110781_bib37","doi-asserted-by":"crossref","first-page":"8602","DOI":"10.1038\/s41598-017-09239-5","article-title":"In vivo regulation of glycogen synthase kinase 3\u03b2 activity in neurons and brains","volume":"7","author":"Krishnankutty","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2025.110781_bib38","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s12035-021-02611-7","article-title":"Implications of phosphoinositide 3-Kinase-Akt (PI3K-Akt) pathway in the pathogenesis of alzheimer's disease","volume":"59","author":"Kumar","year":"2022","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110781_bib39","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12974-023-02853-3","article-title":"Tau and neuroinflammation in Alzheimer's disease: interplay mechanisms and clinical translation","volume":"20","author":"Kyalu Ngoie Zola","year":"2023","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuropharm.2025.110781_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2020.118664","article-title":"Glycogen synthase kinase-3 signaling in Alzheimer's disease","volume":"1867","author":"Lauretti","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/j.neuropharm.2025.110781_bib41","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.matbio.2019.07.004","article-title":"The role of elastin-derived peptides in human physiology and diseases","volume":"84","author":"Le Page","year":"2019","journal-title":"Matrix Biol."},{"key":"10.1016\/j.neuropharm.2025.110781_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232416140","article-title":"HIF-1\u03b1 causes LCMT1\/PP2A deficiency and mediates tau hyperphosphorylation and cognitive dysfunction during chronic hypoxia","volume":"23","author":"Lei","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2025.110781_bib43","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2990.2006.00795.x","article-title":"Increased level of active GSK\u20103\u03b2 in Alzheimer's disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration","volume":"33","author":"Leroy","year":"2007","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.neuropharm.2025.110781_bib44","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.1021\/bi051635j","article-title":"Cyclin-dependent protein kinase 5 primes microtubule-associated protein Tau site-specifically for Glycogen synthase kinase 3\u03b2","volume":"45","author":"Li","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuropharm.2025.110781_bib45","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3233\/JAD-2008-13307","article-title":"Decrease of protein phosphatase 2A and its Association with accumulation and hyperphosphorylation of Tau in Down Syndrome","volume":"13","author":"Liang","year":"2008","journal-title":"J. Alzheim. Dis."},{"key":"10.1016\/j.neuropharm.2025.110781_bib46","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3233\/JAD-215696","article-title":"Cerebrospinal fluid synaptosomal-associated protein 25 levels in patients with alzheimer's disease: a meta-analysis","volume":"89","author":"Liu","year":"2022","journal-title":"J. Alzheim. Dis."},{"key":"10.1016\/j.neuropharm.2025.110781_bib47","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12943-017-0611-1","article-title":"Cdk5 links with DNA damage response and cancer","volume":"16","author":"Liu","year":"2017","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.neuropharm.2025.110781_bib48","doi-asserted-by":"crossref","first-page":"18703","DOI":"10.1002\/anie.201912399","article-title":"Significant upregulation of alzheimer's \u03b2-Amyloid levels in a living system induced by extracellular elastin polypeptides","volume":"58","author":"Ma","year":"2019","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.neuropharm.2025.110781_bib49","doi-asserted-by":"crossref","DOI":"10.1111\/jnc.16039","article-title":"Accumulation of extracellular elastin\u2010derived peptides disturbed neuronal morphology and neuron\u2013microglia crosstalk in aged brain","author":"Ma","year":"2024","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2025.110781_bib50","article-title":"Alterations in extracellular matrix composition during aging and photoaging of the skin","volume":"8","author":"McCabe","year":"2020","journal-title":"Matrix Biol."},{"key":"10.1016\/j.neuropharm.2025.110781_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fnsyn.2023.1129036","article-title":"Alzheimer's disease as a synaptopathy: evidence for dysfunction of synapses during disease progression","volume":"15","author":"Meftah","year":"2023","journal-title":"Front. Synaptic Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110781_bib96","doi-asserted-by":"crossref","unstructured":"Miao J, Shi R, Li L, et al (2019) Pathological Tau From Alzheimer\u2019s Brain Induces Site-Specific Hyperphosphorylation and SDS- and Reducing Agent-Resistant Aggregation of Tau in vivo. Front Aging Neurosci 11:. https:\/\/doi.org\/10.3389\/fnagi.2019.00034.","DOI":"10.3389\/fnagi.2019.00034"},{"key":"10.1016\/j.neuropharm.2025.110781_bib52","doi-asserted-by":"crossref","first-page":"44854","DOI":"10.1074\/jbc.M205630200","article-title":"Signaling pathways transduced through the Elastin receptor facilitate proliferation of arterial smooth muscle cells","volume":"277","author":"Mochizuki","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2025.110781_bib53","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1002\/alz.12749","article-title":"Phosphorylated tau sites that are elevated in Alzheimer's disease fluid biomarkers are visualized in early neurofibrillary tangle maturity levels in the post mortem brain","volume":"19","author":"Moloney","year":"2023","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.neuropharm.2025.110781_bib54","doi-asserted-by":"crossref","first-page":"323","DOI":"10.4161\/trns.22518","article-title":"Ets1 and Elk1 transcription factors regulate cancerous inhibitor of protein phosphatase 2A expression in cervical and endometrial carcinoma cells","volume":"3","author":"Pallai","year":"2012","journal-title":"Transcription"},{"key":"10.1016\/j.neuropharm.2025.110781_bib55","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12929-021-00774-y","article-title":"Three decades of Cdk5","volume":"28","author":"Pao","year":"2021","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.neuropharm.2025.110781_bib56","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0169-328X(02)00488-6","article-title":"Up-regulation of mitogen-activated protein kinases ERK1\/2 and MEK1\/2 is associated with the progression of neurofibrillary degeneration in Alzheimer's disease","volume":"109","author":"Pei","year":"2002","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.neuropharm.2025.110781_bib57","doi-asserted-by":"crossref","first-page":"658","DOI":"10.14336\/AD.2024.0286","article-title":"Amyloid-\u03b2 and phosphorylated tau are the key biomarkers and predictors of alzheimer's disease","volume":"16","author":"Pradeepkiran","year":"2025","journal-title":"Aging Dis"},{"key":"10.1016\/j.neuropharm.2025.110781_bib65","doi-asserted-by":"crossref","unstructured":"P. Sharma, Veeranna, M. Sharma, N.D. Amin, R.K. Sihag, P. Grant, N. Ahn, A.B. Kulkarni, H.C. Pant, Phosphorylation of MEK1 by cdk5\/p35 Down-regulates the Mitogen-activated Protein Kinase Pathway, J. Biol. Chem. 277 (2002) 528\u2013534. https:\/\/doi.org\/10.1074\/jbc.M109324200.","DOI":"10.1074\/jbc.M109324200"},{"key":"10.1016\/j.neuropharm.2025.110781_bib58","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jdermsci.2015.10.001","article-title":"Synthetic ligands of the elastin receptor induce elastogenesis in human dermal fibroblasts via activation of their IGF-1 receptors","volume":"80","author":"Qa\u2019aty","year":"2015","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.neuropharm.2025.110781_bib98","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1750-1326-2-12","article-title":"Tau phosphorylation by GSK-3\u03b2 promotes tangle-like filament morphology","volume":"2","author":"Rankin","year":"2007","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.neuropharm.2025.110781_bib59","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.stemcr.2019.01.015","article-title":"Dual inhibition of GSK3\u03b2 and CDK5 protects the Cytoskeleton of neurons from neuroinflammatory-mediated degeneration in vitro and in vivo","volume":"12","author":"Reinhardt","year":"2019","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.neuropharm.2025.110781_bib60","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1016\/j.yexcr.2006.04.021","article-title":"(R)-Roscovitine (CYC202, Seliciclib) sensitizes SH-SY5Y neuroblastoma cells to nutlin-3-induced apoptosis","volume":"312","author":"Ribas","year":"2006","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.neuropharm.2025.110781_bib61","doi-asserted-by":"crossref","DOI":"10.1590\/1678-4685-gmb-2019-0404","article-title":"Influence of a genetic variant of CHAT gene over the profile of plasma soluble ChAT in Alzheimer disease","volume":"43","author":"Rocha-Dias","year":"2020","journal-title":"Genet. Mol. Biol."},{"key":"10.1016\/j.neuropharm.2025.110781_bib62","doi-asserted-by":"crossref","first-page":"4052","DOI":"10.3390\/ijms19124052","article-title":"Perspectives of RAS and RHEB GTPase signaling pathways in regenerating brain neurons","volume":"19","author":"Sch\u00f6neborn","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2025.110781_bib63","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1523\/JNEUROSCI.5927-11.2012","article-title":"Regulation of mitochondrial transport and inter-microtubule spacing by Tau phosphorylation at the sites hyperphosphorylated in alzheimer's disease","volume":"32","author":"Shahpasand","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110781_bib64","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1172\/JCI115204","article-title":"Marked longevity of human lung parenchymal elastic fibers deduced from prevalence of D-aspartate and nuclear weapons-related radiocarbon","volume":"87","author":"Shapiro","year":"1991","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.neuropharm.2025.110781_bib66","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.celrep.2018.06.009","article-title":"CIP2A causes Tau\/APP phosphorylation, synaptopathy, and memory deficits in alzheimer's disease","volume":"24","author":"Shentu","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuropharm.2025.110781_bib67","first-page":"1","article-title":"Differentiation of the SH-SY5Y human neuroblastoma cell line","author":"Shipley","year":"2016","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.neuropharm.2025.110781_bib68","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.arcmed.2012.10.015","article-title":"Deregulated Cdk5 activity is involved in inducing alzheimer's disease","volume":"43","author":"Shukla","year":"2012","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.neuropharm.2025.110781_bib69","doi-asserted-by":"crossref","first-page":"8948","DOI":"10.3390\/ijms21238948","article-title":"Tauopathies: deciphering disease mechanisms to develop effective therapies","volume":"21","author":"Silva","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2025.110781_bib70","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.lfs.2018.10.056","article-title":"Matrikines for therapeutic and biomedical applications","volume":"214","author":"Sivaraman","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2025.110781_bib71","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1136\/jnnp.70.5.624","article-title":"Both total and phosphorylated tau are increased in Alzheimer's disease","volume":"70","author":"Sjogren","year":"2001","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110781_bib72","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1007\/s00204-023-03552-x","article-title":"Suppression of sonic hedgehog pathway-based proliferation in glioblastoma cells by small-size silver nanoparticles in vitro","volume":"97","author":"Sk\u00f3ra","year":"2023","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.neuropharm.2025.110781_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2022.116339","article-title":"Crosstalk between the aryl hydrocarbon receptor (AhR) and the peroxisome proliferator-activated receptor gamma (PPAR\u03b3) as a key factor in the metabolism of silver nanoparticles in neuroblastoma (SH-SY5Y) cells in vitro","volume":"458","author":"Sk\u00f3ra","year":"2023","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110781_bib74","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s12035-024-04298-y","article-title":"Interaction between aging-related elastin-derived peptide (VGVAPG) and Sirtuin 2 and its impact on functions of Human neuron cells in an In vitro model","volume":"62","author":"Sk\u00f3ra","year":"2025","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2025.110781_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2025.105992","article-title":"Proteostasis and autophagy disruption by the aging-related VGVAPG hexapeptide - preliminary insights into a potential novel elastin-induced neurodegeneration pathway in an in vitro human cellular neuron model","volume":"187","author":"Sk\u00f3ra","year":"2025","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2025.110781_bib76","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.yexcr.2018.01.001","article-title":"PTEN silencing enhances neuronal proliferation and differentiation by activating PI3K\/Akt\/GSK3\u03b2 pathway in vitro","volume":"363","author":"Song","year":"2018","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.neuropharm.2025.110781_bib97","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s40478-021-01259-7","article-title":"Loss of presenilin function enhances tau phosphorylation and aggregation in mice","volume":"9","author":"Soto-Fagu\u00e1s","year":"2021","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.neuropharm.2025.110781_bib77","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.3892\/ijmm.2017.2962","article-title":"The extracellular signal-regulated kinase 1\/2 pathway in neurological diseases: a potential therapeutic target","volume":"39","author":"Sun","year":"2017","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.neuropharm.2025.110781_bib99","doi-asserted-by":"crossref","unstructured":"Sun L-H, Ban T, Liu C-D, et al (2015) Activation of Cdk5\/p25 and tau phosphorylation following chronic brain hypoperfusion in rats involves microRNA-195 down-regulation. J Neurochem 134:1139\u20131151. https:\/\/doi.org\/10.1111\/jnc.13212.","DOI":"10.1111\/jnc.13212"},{"key":"10.1016\/j.neuropharm.2025.110781_bib78","doi-asserted-by":"crossref","DOI":"10.1007\/s12640-019-00040-y","article-title":"Antiproliferative effect of elastin-derived peptide VGVAPG on SH-SY5Y neuroblastoma cells","author":"Szychowski","year":"2019","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.neuropharm.2025.110781_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2024.156725","article-title":"Elastin-derived peptides (EDPs) affect gene and protein expression in human mesenchymal stem cells (hMSCs) \u2013 preliminary study","volume":"182","author":"Szychowski","year":"2024","journal-title":"Cytokine"},{"key":"10.1016\/j.neuropharm.2025.110781_bib80","article-title":"Elastin-Derived peptides in the central nervous system: friend or foe","author":"Szychowski","year":"2021","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2025.110781_bib81","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S1097-2765(01)00343-4","article-title":"Structure and regulation of the CDK5-p25nck5a complex","volume":"8","author":"Tarricone","year":"2001","journal-title":"Mol. Cell"},{"key":"10.1016\/j.neuropharm.2025.110781_bib82","doi-asserted-by":"crossref","DOI":"10.1002\/cpz1.276","article-title":"Protocols for characterization of Cdk5 Kinase activity","volume":"1","author":"Terse","year":"2021","journal-title":"Curr. Protoc."},{"key":"10.1016\/j.neuropharm.2025.110781_bib83","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003108","article-title":"N-Acetylcholinesterase-Induced apoptosis in alzheimer's disease","volume":"3","author":"Toiber","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2025.110781_bib84","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/jat.3334","article-title":"Characterization of three human cell line models for high-throughput neuronal cytotoxicity screening","volume":"37","author":"Tong","year":"2017","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.neuropharm.2025.110781_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121918","article-title":"Spontaneous and familial models of Alzheimer's disease: challenges and advances in preclinical research","volume":"328","author":"Ulaganathan","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2025.110781_bib86","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.neurobiolaging.2014.07.035","article-title":"Cross talk between PI3K-AKT-GSK-3\u03b2 and PP2A pathways determines tau hyperphosphorylation","volume":"36","author":"Wang","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2025.110781_bib100","doi-asserted-by":"crossref","first-page":"103626","DOI":"10.1016\/j.etap.2021.103626","article-title":"Prolonged arsenic exposure increases tau phosphorylation in differentiated SH-SY5Y cells: The contribution of GSK3 and ERK1\/2","volume":"84","author":"Wisessaowapak","year":"2021","journal-title":"Environ Toxicol Pharmacol"},{"key":"10.1016\/j.neuropharm.2025.110781_bib87","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/s12276-025-01455-8","article-title":"ELK1 inhibition alleviates amyloid pathology and memory decline by promoting the SYVN1-mediated ubiquitination and degradation of PS1 in Alzheimer's disease","volume":"57","author":"Yi","year":"2025","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.neuropharm.2025.110781_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2025.120236","article-title":"SNAP-25: a biomarker of synaptic loss in neurodegeneration","volume":"571","author":"Zhang","year":"2025","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.neuropharm.2025.110781_bib89","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1007\/s12013-024-01415-5","article-title":"CDK5 upregulated by ELF3 transcription promotes IL-1\u03b2-induced inflammation and extracellular matrix degradation in human chondrocytes","volume":"82","author":"Zhang","year":"2024","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.neuropharm.2025.110781_bib90","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14818","article-title":"GSK3: a potential target and pending issues for treatment of Alzheimer's disease","volume":"30","author":"Zhao","year":"2024","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.neuropharm.2025.110781_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2023.105571","article-title":"Antidepressants escitalopram and venlafaxine up-regulate BDNF promoter IV but down-regulate neurite outgrowth in differentiating SH-SY5Y neurons","volume":"169","author":"Zosen","year":"2023","journal-title":"Neurochem. Int."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825004897?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825004897?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T15:18:15Z","timestamp":1781191095000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390825004897"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":100,"alternative-id":["S0028390825004897"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110781","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multi-kinase-mediated alterations in Tau phosphorylation, synaptic proteins, and choline metabolism in a human neuronal in vitro model exposed to the elastin-derived hexapeptide VGVAPG","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110781","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110781"}}